Treatment of MDA-MB-231 human breast cancer cell cultures with this phenolic compound inhibited NF-κB-mediated expression of CXCL-1 and -2 pro-inflammatory cytokines by preventing IκB phosphorylation [250]. This evidence concerns the gene NFKB1 and breast carcinoma.